Skip to main content

Blood Bank

Elutions

Elution is a technique we use when we know red blood cells are coated with antibody in vivo (because the Direct Antiglobulin Test - DAT - is positive), and we want to figure out exactly which antibody is doing the coating

Think of it as gently prying the antibody off the red blood cell so we can capture it and test it separately. It’s the detective work after the DAT alarm bell has rung!

The Core Purpose: Identifying Bound Antibody

The primary goal of an elution procedure is to recover intact antibodies that have bound to red blood cells in vivo, allowing for identification of their specificity

We perform elutions almost exclusively when a patient has a positive Direct Antiglobulin Test (DAT), especially in these key scenarios:

  • Hemolytic Disease of the Fetus and Newborn (HDFN): To identify the maternal antibody (e.g., anti-D, anti-K) coating the newborn’s red blood cells
  • Transfusion Reaction Investigation: To identify a recipient antibody coating transfused donor red blood cells (e.g., patient anti-Jka coating transfused Jk(a+) cells)
  • Autoimmune Hemolytic Anemia (AIHA): To identify the specificity of the autoantibody coating the patient’s own red blood cells (though often it’s broadly reactive or has a common Rh specificity like anti-e)
  • Drug-Induced Hemolytic Anemia (DIHA): To help determine if antibody coating the cells is drug-dependent

The Starting Material: Antibody-Coated RBCs

The input for an elution is thoroughly washed red blood cells from the individual with the positive DAT (patient sample, cord blood sample, or post-reaction sample)

  • WASHING IS PARAMOUNT!: This cannot be stressed enough. The cells must be washed meticulously (often 6-8 times or more, using large volumes of saline) to remove all traces of unbound antibody from the surrounding plasma. If plasma antibodies contaminate the sample, they will end up in the final eluate, leading to a false-positive or misleading result. We only want to recover the antibody that was actually stuck to the cells
  • Last Wash Control: As a critical quality control step, the supernatant fluid from the final wash is saved and tested in parallel with the eluate. This last wash control MUST BE NEGATIVE. If it shows reactivity, it indicates insufficient washing, and the elution results are invalid

The Basic Principle: Disrupting the Antigen-Antibody Bond

Elution methods work by manipulating the physical conditions to break the chemical bonds holding the antibody to the red cell antigen, without (ideally) destroying the antibody itself. Once the bond is broken, the antibody is released into the surrounding fluid (the eluting solution)

Common Elution Methods

Different methods use different stresses to break the bonds:

Acid Elution (e.g., Glycine Acid, Citric Acid)

  • Mechanism: Lowers the pH of the environment (typically to around 3.0). This disrupts the electrostatic and hydrogen bonds between the antigen and antibody, causing the antibody to dissociate
  • Procedure: Washed packed RBCs are mixed with the acid solution, incubated briefly, then centrifuged immediately. The supernatant fluid (containing the released antibody) is harvested and immediately buffered back to a physiological pH (around 7.0) to prevent denaturation of the antibody by the acid
  • Pros: Relatively fast, simple, and generally effective for recovering IgG antibodies, especially ABO antibodies in cases of HDFN
  • Cons: Requires rapid buffering to maintain antibody activity. May not be as effective for all antibody types

Heat Elution

  • Mechanism: Uses increased temperature (typically 56°C) to weaken the antigen-antibody bonds
  • Procedure: Washed packed RBCs are suspended in saline or albumin, incubated at 56°C for about 10 minutes, then centrifuged while still hot. The supernatant eluate is harvested immediately
  • Pros: Simple technique. Particularly good for detecting ABO antibodies in HDFN investigations involving cord blood cells
  • Cons: Less sensitive than acid or solvent methods for many non-ABO IgG antibodies. Heat can potentially denature some antibodies

Freeze-Thaw Elution (Lui Easy Freeze Method)

  • Mechanism: Rapid freezing causes ice crystal formation, which lyses the red blood cells. The process likely disrupts the antigen-antibody interaction, releasing the antibody
  • Procedure: Washed packed RBCs are resuspended in a small volume of saline or ABO-compatible serum, frozen rapidly (e.g., in an alcohol/dry ice bath or -70°C freezer), then thawed quickly (e.g., in a 37°C water bath). The mixture is centrifuged, and the hemoglobin-stained supernatant (eluate) is harvested
  • Pros: Very simple and fast. Effective for detecting ABO antibodies in HDFN
  • Cons: Generally less sensitive than acid elution for detecting other IgG antibodies

Organic Solvent Elution (e.g., Dichloromethane, Xylene, Ether - Less Common / Reference Lab)

  • Mechanism: Organic solvents disrupt hydrophobic bonds involved in antigen-antibody interactions and also affect the lipid bilayer of the red cell membrane, causing antibody release
  • Procedure: Involves mixing washed RBCs with the solvent, agitation, centrifugation to separate layers, and careful harvesting of the aqueous eluate layer
  • Pros: Historically considered very effective for recovering various IgG antibodies, especially non-ABO types
  • Cons: SIGNIFICANT SAFETY HAZARDS! These solvents are often flammable, volatile, and toxic, requiring use in specialized fume hoods and careful disposal. Due to safety concerns, they have been largely replaced by safer methods like acid elution in routine clinical labs. Primarily used in reference settings now

Testing the Eluate

Once harvested, the eluate (the fluid containing the recovered antibody) is tested like serum or plasma against a panel of reagent red blood cells (Group O panel cells) using an Indirect Antiglobulin Test (IAT) method (often LISS or PEG) to determine the antibody’s specificity

Interpretation

  • Specificity Identified: If the eluate reacts with panel cells in a specific pattern (e.g., reacts only with D-positive cells), it identifies the antibody coating the cells (e.g., anti-D)
  • Panreactive Eluate: If the eluate reacts with all panel cells tested (and the last wash control is negative), it usually indicates a warm autoantibody is coating the cells. Further testing on the patient’s serum (often after adsorption) is needed to rule out underlying alloantibodies
  • Negative Eluate: If the eluate is non-reactive with the panel cells (and the last wash control is negative), it could mean:
    • The DAT was positive due to complement coating only (and the elution method used doesn’t recover complement)
    • The antibody was too weak to be detected after elution
    • The antibody detached during the washing process (unlikely if done correctly)
    • The elution procedure failed or denatured the antibody
    • The initial DAT was a false positive

Key Terms

  • Elution: The process of recovering antibodies that have bound to red blood cells (usually in vivo) by disrupting the antigen-antibody bonds
  • Eluate: The fluid containing the antibodies recovered during the elution procedure
  • Direct Antiglobulin Test (DAT): Test used to detect IgG or complement coating red blood cells in vivo. A positive DAT is the primary indication for performing an elution
  • In Vivo Sensitization: The coating of red blood cells with antibody or complement within the patient’s body
  • Last Wash Control: A quality control step where the supernatant from the final wash of the red blood cells (before adding the eluting solution) is tested in parallel with the eluate. It must be non-reactive for the elution results to be valid
  • Acid Elution: Elution method using low pH to dissociate antibodies
  • Heat Elution: Elution method using elevated temperature (e.g., 56°C) to dissociate antibodies
  • Freeze-Thaw Elution: Elution method using rapid freezing and thawing to lyse cells and release antibodies
  • Organic Solvent Elution: Elution method using chemicals like dichloromethane or ether to dissociate antibodies (less common due to safety)
  • Specificity: The particular antigen(s) that an antibody recognizes and binds to